Biomedical Engineering Reference
In-Depth Information
972. Chiao JH, Roy K, Tolner B, Yang C, Sirotnak FM. 1997. RFC-1 Gene expression
regulates folate absorption in mouse small intestine. J Biol Chem 272: 11165-11170.
973. McGuire JJ, Haile WH, Yeh CC. 2006. 5-Amino-4-imidazolecarboxamide riboside
potentiates both transport of reduced folates and antifolates by the human reduced folate
carrier and their subsequent metabolism. Cancer Res 66: 3836-3844.
974. Prouse PJ, Shawe D, Gumpel JM. 1986. Macrocytic anaemia in patients treated with
sulphasalazine for rheumatoid arthritis. Br Med J 293:1407.
975. Swinson CM, Perry J, Lumb M, Levi AJ. 1981. Role of sulfasalazine in the aetiology of
folate deficiency in ulcerative colitis. Gut 22: 456-461.
976. Shiroky JB. 1993. Unsubstantiated “risk” of antifolate toxicity with combination
methotrexate and sulfasalazine therapy. Arthritis Rheum 12: 1757-1758.
977. Longstreth GF, Green R. 1983. Folate status in patients receiving maintenance doses of
sulfasalazine. Arch Intern Med 143: 902-904.
978. Zimmerman J. 1992. Drug interactions in intestinal transport of folic acid and methotrex-
ate: further evidence for the heterogeneity of folate transport in the human small intestine.
Biochem Pharmacol 44: 1839-1842.
979. Haagsma CJ, Russel FG, Vree TB, van Riel PL, van de Putte LB. 1996. Combination
of methotrexate and sulfasalazine in patients with rheumatoid arthritis: pharmacokinetic
analysis and relationship to clinical response. Br J Clin Pharmacol 42: 195-200.
980. Haagsma CJ, van Riel PL, da Jong AJ, van de Putte LB. 1997. Combination of
sulfasalazine and methotrexate versus the single components in early rheumatoid
arthritis: a randomized, controlled, double-blind, 52 week clinical trial. Br J Rheumatol
36: 1082-1088.
981. Haagsma CJ, Blom HJ, van Riel PL, van't Hof MA, Giesendorf BA, Oppenraaij-
Emmerzaal D, van de Putte LB. 1999. Influence of sulphasalazine, methotrexate, and the
combination of both on plasma homocysteine concentrations in patients with rheumatoid
arthritis. Ann Rheum Dis 58: 79-84.
982. Chung JY, Cho JY, Yu KS, Kim JR, Oh DS, Jung HR, Lim KS, Moon KH, Shin SG,
Jang IJ. 2005. Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics
of pitavastatin in healthy volunteers. Clin Pharmacol Ther 78: 342-350.
983. Poole RC, Halestrap AP. 1991. Reversible and irreversible inhibition, by stil-
benedisulphonates, of lactate transport into rat erythrocytes: identification of some new
high-affinity inhibitors. Biochem J 275: 307-312.
984. Bonen A, McCullagh KJ, Putman CT, Hultman E, Jones NL, Heigenhauser GJ. 1998.
Short-term training increases human muscle MCT1 and femoral venous lactate in
relation to muscle lactate. Am J Physiol 274: E102-E107.
985. Py G, Lambert K, Milhavet O, Eydoux N, Prefaut C, Mercier J. 2002. Effects of
streptozotocin-induced diabetes on markers of skeletal muscle metabolism and mono-
carboxylate transporter 1 to monocarboxylate transporter 4 transporters. Metabolism 51:
807-813.
